AT-20 SINGLE INSTITUTION RETROSPECTIVE REVIEW OF PERFORMANCE STATUS AND CORTICOSTEROID USE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS (PTS) TREATED ON BEVACIZUMAB (BEV)

BACKGROUND: Two multicenter phase III trials, RTOG0825 and AVAglio, evaluated the addition of BEV to radiation and temozolomide in newly diagnosed GBM and demonstrated a lack of statistically significant increased survival and discordant health-related quality of life results. We performed a retrosp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Desjardins, Annick, Herndon, James, McSherry, Frances, Ravelo, Arliene, Lipp, Eric, Healy, Patrick, Peters, Katherine, Vlahovic, Gordana, Sampson, John, Friedman, Allan, Friedman, Henry
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217798/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados